Koers Chongqing Zhifei Biological Products Co., Ltd.
Aandelen
300122
CNE100000V20
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
45,27 CNY | -0,37% | -6,49% | -25,92% |
Omzet 2023 * | 49,89 mld. 6,91 mld. 6,4 mld. | Omzet 2024 * | 59,7 mld. 8,27 mld. 7,66 mld. | Marktkapitalisatie | 108 mld. 14,94 mld. 13,84 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | 8,95 mld. 1,24 mld. 1,15 mld. | Nettowinst (verlies) 2024 * | 11,29 mld. 1,56 mld. 1,45 mld. | EV/omzet 2023 * | 2,02 x |
Nettoliquiditeiten 2023 * | 7,02 mld. 973 mln. 901 mln. | Nettoliquiditeiten 2024 * | 13,16 mld. 1,82 mld. 1,69 mld. | EV/omzet 2024 * | 1,59 x |
K/w-verhouding 2023 * |
12
x | K/w-verhouding 2024 * |
9,71
x | Werknemers | 5.735 |
Dividendrendement 2023 * |
0,95% | Dividendrendement 2024 * |
1,1% | Vrij verhandelbaar | 14,73% |
1 dag | -0,37% | ||
1 week | -6,49% | ||
Lopende maand | -15,37% | ||
1 maand | -14,46% | ||
3 maanden | -24,21% | ||
6 maanden | -6,99% | ||
Lopend jaar | -25,92% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hai Ping Xu
CHM | Chairman | 43 | 01-01-14 |
Zhen Jing Li
DFI | Director of Finance/CFO | 42 | 01-01-14 |
Ren Sheng Jiang
CHM | Chairman | 71 | 17-08-09 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ren Sheng Jiang
CHM | Chairman | 71 | 17-08-09 |
Ling Feng Jiang
BRD | Director/Board Member | 44 | 01-08-12 |
Lin Du
BRD | Director/Board Member | 59 | 11-04-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
2.58% | 12 M€ | -16,71% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 45,27 | -0,37% | 18 415 990 |
27-03-24 | 45,44 | -3,22% | 16 721 170 |
26-03-24 | 46,95 | +0,84% | 20 766 680 |
25-03-24 | 46,56 | -1,61% | 17 010 850 |
22-03-24 | 47,32 | -2,25% | 17 780 050 |
slotkoers Shenzhen S.E., 28 maart 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-25,92% | 15,03 mld. | |
+0,44% | 90,78 mld. | |
+9,61% | 43,96 mld. | |
-16,67% | 31,34 mld. | |
+44,99% | 23,45 mld. | |
-9,42% | 16,48 mld. | |
-9,27% | 12,79 mld. | |
-7,57% | 12,19 mld. | |
+0,07% | 8,5 mld. | |
+110,66% | 8,15 mld. |